Your browser doesn't support javascript.
loading
Inhibition of TGF-ß signaling, vasculogenic mimicry and proinflammatory gene expression by isoxanthohumol.
Serwe, Annegret; Rudolph, Kristina; Anke, Timm; Erkel, Gerhard.
Afiliação
  • Serwe A; Institute of Biotechnology and Drug Research (IBWF e. V.), Erwin-Schrödinger-Str.56, 67663, Kaiserslautern, Germany.
Invest New Drugs ; 30(3): 898-915, 2012 Jun.
Article em En | MEDLINE | ID: mdl-21340508
ABSTRACT
TGF-ß is a multifunctional cytokine that regulates cell proliferation, differentiation, apoptosis and extracellular matrix production. Deregulation of TGF-ß production or signaling has been associated with a variety of pathological processes such as cancer, metastasis, angiogenesis and fibrosis. Therefore, TGF-ß signaling has emerged as an attractive target for the development of new cancer therapeutics. In a screening program of natural compounds from fungi inhibiting the TGF-ß dependent expression of a reporter gene in HepG2 cells, we found that the flavone isoxanthohumol inhibited the binding of the activated Smad2/3 transcription factors to the DNA and antagonized the cellular effects of TGF-ß including reporter gene activation and expression of TGF-ß induced genes in HepG2 and MDA-MB-231 cells. In an in vitro angiogenesis assay, isoxanthohumol (56 µM) strongly decreased the formation of capillary-like tubules of MDA-MB-231 cells on Matrigel. In addition, we found that isoxanthohumol blocked IFN-γ, IL-4 and IL-6 dependent Jak/Stat signaling and strongly inhibited the induction of pro-inflammatory genes in MonoMac6 cells at the transcriptional level after LPS/TPA treatment.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator de Crescimento Transformador beta / Xantonas / Antineoplásicos Limite: Humans Idioma: En Revista: Invest New Drugs Ano de publicação: 2012 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator de Crescimento Transformador beta / Xantonas / Antineoplásicos Limite: Humans Idioma: En Revista: Invest New Drugs Ano de publicação: 2012 Tipo de documento: Article